Maven Income and Growth VCT 4 PLC (MAV4.L)
GBp 57.5
(0.0%)
GBp 57.5
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.3 Million | -2.18 Million | -3.1 Million | -1.09 Million | -120 Thousand | -1 Million |
| Net Income | -4.3 Million | -2.06 Million | 9.39 Million | 2.72 Million | 1.17 Million | 361 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 10 Thousand | -906 Thousand | -349 Thousand | 652 Thousand | 202 Thousand | -283 Thousand |
| Other non-cash items | 2.98 Million | 787 Thousand | -12.14 Million | -4.46 Million | -1.49 Million | -1.08 Million |
| Investing Cash Flow | -13.26 Million | 3.59 Million | 4.64 Million | -5.39 Million | -19.02 Million | -12.74 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -19.58 Million | -5.47 Million | -5.03 Million | -12.38 Million | -23.5 Million | -15.54 Million |
| Sales/Maturities of investments | 6.32 Million | 9.06 Million | 9.67 Million | 6.99 Million | 4.47 Million | 2.79 Million |
| Other Investing Activities | -13.26 Million | 3.59 Million | 4.64 Million | -5.39 Million | -19.02 Million | -12.74 Million |
| Financing Cash Flow | -323 Thousand | 8.4 Million | -5.85 Million | 2.93 Million | 16.99 Million | 22.71 Million |
| Debt repayment | - | -14.73 Million | -1.41 Million | -38 Thousand | - | - |
| Dividends payments | -4.78 Million | -6.33 Million | -4.43 Million | -3.36 Million | -1.51 Million | -6.54 Million |
| Common Stock Repurchased | -2.71 Million | -1.71 Million | -1.81 Million | -1.15 Million | -786 Thousand | -596 Thousand |
| Common Stock Issuance | 7.17 Million | 16.44 Million | 397 Thousand | 7.5 Million | 19.3 Million | 29.86 Million |
| Other Financing Activities | 7.17 Million | 14.73 Million | 1.41 Million | -14 Thousand | -9000.00 | 29.86 Million |
| Accounts receivables | 3000.00 | -155 Thousand | -448 Thousand | 11 Thousand | 82 Thousand | -82 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 7000.00 | -751 Thousand | 99 Thousand | 641 Thousand | 120 Thousand | -201 Thousand |
| Cash at beginning of period | 20.35 Million | 10.54 Million | 14.85 Million | 18.4 Million | 20.55 Million | 11.58 Million |
| Cash at end of period | 5.45 Million | 20.35 Million | 10.54 Million | 14.85 Million | 18.4 Million | 20.55 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -14.89 Million | 9.81 Million | -4.31 Million | -3.55 Million | -2.15 Million | 8.96 Million |
| Free Cash Flow | -1.3 Million | -2.18 Million | -3.1 Million | -1.09 Million | -120 Thousand | -1 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.61 Million | 1.61 Million | -973 Thousand | -4.3 Million | -973 Thousand | -2.36 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 5000.00 | 10 Thousand | 5000.00 | - |
| Other non-cash items | -1.91 Million | -1.91 Million | 645 Thousand | 2.98 Million | 645 Thousand | 1.69 Million |
| Investing Cash Flow | -853 Thousand | -853 Thousand | -1.79 Million | -13.26 Million | -1.79 Million | -9.68 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -7.56 Million | - | -8.43 Million | -19.58 Million | - | -11.15 Million |
| Sales/Maturities of investments | 5.86 Million | - | 4.85 Million | 6.32 Million | - | 1.46 Million |
| Other Investing Activities | -853 Thousand | -853 Thousand | -1.79 Million | -13.26 Million | -1.79 Million | -4.84 Million |
| Financing Cash Flow | 1.05 Million | 1.05 Million | -1.86 Million | -323 Thousand | -1.86 Million | 3.41 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -2.51 Million | -1.25 Million | -1.19 Million | -4.78 Million | -1.19 Million | -2.39 Million |
| Common Stock Repurchased | -642.5 Thousand | -642.5 Thousand | -785 Thousand | -2.71 Million | -785 Thousand | -1.14 Million |
| Common Stock Issuance | 5.89 Million | - | 225 Thousand | 7.17 Million | - | 6.95 Million |
| Other Financing Activities | 2.94 Million | 2.94 Million | 112.5 Thousand | 7.17 Million | 112.5 Thousand | 3.47 Million |
| Accounts receivables | - | - | 1500.00 | 3000.00 | 1500.00 | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | 3500.00 | 7000.00 | 3500.00 | - |
| Cash at beginning of period | 5.45 Million | - | 13.41 Million | 20.35 Million | - | 20.35 Million |
| Cash at end of period | 5.24 Million | -107.5 Thousand | 5.45 Million | 5.45 Million | -3.98 Million | 13.41 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -215 Thousand | -107.5 Thousand | -7.96 Million | -14.89 Million | -3.98 Million | -6.93 Million |
| Free Cash Flow | -306 Thousand | -306 Thousand | -323 Thousand | -1.3 Million | -323 Thousand | -662 Thousand |
300323
PWUP
HEALTHYLIFE
HRTIS
OOA
MXF